Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients
- Conditions
- Acute Coronary Syndrome
- Interventions
- Other: SprintsOther: Vertical jumpsOther: Questionary Short Form-12 (SF-12)Device: activity actigraphOther: Program of usual practiceOther: Program composed of two 2 training strategies
- Registration Number
- NCT04102410
- Brief Summary
Cardiac rehabilitation includes aerobic and anaerobic training adapted to cardiovascular pathology for which cardiac rehabilitation is prescribed. It is essential to adapt the content of these cardiac rehabilitation sessions to optimize aerobic and anaerobic performance and quality of life. Improvement of the first ventilatory threshold is one of the main objectives since it illustrates the adaptation of the patient to submaximal exercise, typical of everyday life.
The research laboratory "Autonomous Nervous System - Epidemiology, Physiology, Engineering, Health" (SPA-EPIS) has an international expertise in training optimization in top-athletes. He have shown the importance of the relationship between the power-force-velocity profile and athletes performances.
- Detailed Description
In this sudy, each patient has a force and a velocity that can be optimized with training to achieve maximum power. This optimization can be evaluated through a force-velocity profile, measured from an only sprint on a cycloergometer.
The hypothesis that force-velocity profile could be used in cardiac rehabilitation in coronary patients to induce a force-velocity balance adapted through personalized sessions and regular medical follow-up.
This prospective, controlled, randomized and open label study will attempt to evaluate further the relevance of force or velocity training based on the initial force-velocity profile of coronary patients included in the cardiac rehabilitation program in the University Hospital of Saint-Etienne.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Acute coronary syndrome treated within the last 6 months
- Medical revascularization (angioplasty ± stenting) or surgical (coronary artery bypass)
- During initial effort test: Maximum aerobic power≥ 60 watts for women and ≥ 80 watts for men
- Patient affiliated or beneficiary to social security
- Signed informed consent
- Significant co-morbidities limited practice of physical activity
- Inability to submit to medical monitoring of the program
- Patient deprived of liberty or patient under guardianship
- Pregnant woman
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental group Vertical jumps Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program composed of two 2 training strategies. Experimental group Sprints Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program composed of two 2 training strategies. Experimental group Questionary Short Form-12 (SF-12) Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program composed of two 2 training strategies. Control group Vertical jumps Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program of usual practice. Control group Sprints Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program of usual practice. Control group Program of usual practice Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program of usual practice. Experimental group activity actigraph Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program composed of two 2 training strategies. Experimental group Program composed of two 2 training strategies Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program composed of two 2 training strategies. Control group activity actigraph Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program of usual practice. Control group Questionary Short Form-12 (SF-12) Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program of usual practice.
- Primary Outcome Measures
Name Time Method volume of oxygen consumed (VO2) (in ml/min/kg) at the first ventilatory threshold (SV1) Months: 0 and 2 Change in VO2 (volume of oxygen in ml/min/kg) at the first ventilatory threshold (SV1) during a Cardio-Pulmonary Exercise Test (CPET).
- Secondary Outcome Measures
Name Time Method Voluntary muscle power (in kg) during a dynamic muscle testing on quadriceps Months: 0 and 2 Comparison voluntary muscle power (in kg) during a dynamic muscle testing on quadriceps.
Sedentary life (in hour/day) Month: 0 Assessment of Sedentary life (in hour/day). Measured by activity actigraph.
Maximum aerobic power (in watt) Months: 0 and 2 Comparison maximum aerobic power (in watt) during a Cardio-Pulmonary Exercise Test (CPET).
Physical activity (in Metabolic Equivalent of Task (MET)-min/week) Month: 0 Assessment of Physical activity (in Metabolic Equivalent of Task (MET)-min/week).
Measured by activity actigraph.SF-12 questionnaire score Months: 0 and 2 The SF-12 is a self-questionnaire to assess the quality of life. This tool is an abbreviated version of the "Medical Outcomes Study Short-Form General Health Survey" (SF-36) contains only 12 items out of 36 with minimum score 0 (bad quality life) and maximum score at 100 (good quality life).
VO2 max (volume of oxygen maximum in ml/min/kg) Months: 0 and 2 Comparison VO2 max (volume of oxygen maximum in ml/min/kg) during a Cardio-Pulmonary Exercise Test (CPET).
Value of muscular endurance (in min) during a dynamic muscle testing on quadriceps Months: 0 and 2 Comparison value of muscular endurance (in min) during a dynamic muscle testing on quadriceps.
Standard Deviation of the Normal R-R interval (SDNN) index Months: 0 and 2 Measured by holter electrocardiogram during 24 hours.
Power at first ventilatory threshold (SV1) Months: 0 and 2 Comparison value of power at first ventilatory threshold (SV1) during a Cardio-Pulmonary Exercise Test (CPET).
Voluntary muscle power (in kg) during a static muscle testing on quadriceps Months: 0 and 2 Comparison voluntary muscle power (in kg) during a static muscle testing on quadriceps.
Value of muscular endurance (in min) during a static muscle testing on quadriceps Months: 0 and 2 Comparison value of muscular endurance (in min) during a static muscle testing on quadriceps.
BaroReflex Sensitivity (BRS) (in ms/mmHg) Months: 0 and 2 Measured by baroreflex.
Trial Locations
- Locations (1)
Chu Saint-Etienne
🇫🇷Saint-Étienne, France